ORAL EPITHELIAL CELL CYTOKINES CANDIDA & PMN ACTIVATION

口腔上皮细胞细胞因子念珠菌

基本信息

项目摘要

DESCRIPTION: (abstract verbatim) Oropharyngeal candidiasis is particularly prevalent in patients who are immunocompromised by disease or immunosuppressive treatment. Interestingly, even in immunocompromised patients invasive oral candidiasis is rare and seems to be associated with additional risk factors such as extreme neutropenia. One strategy for improving resistance to opportunistic pathogens is to define host cellular responses during the invasion process and enhance those responses that are relevant to defense mechanisms. Compelling experimental evidence suggests that the primary effector cell responsible for Candida clearance is the neutrophil. Neutrophils accumulate rapidly at the site of infection in the oral cavity and participate in the local control of Candida growth and invasion, yet very little is known about the host signals responsible for regulating these events. Several cytokines provide signals for neutrophil activation of antifungal functions, including interleukin-1 beta (IL-1b) and granulocyte macrophage colony stimulating factor (GM-CSF). In cases of T-helper cell depletion or inactivation, such as HIV disease or Cyclosporin A treatment, PMN are most likely potentiated in their anti-fungal function by stimulating cytokines derived from non-immune cell. Epithelial cells are capable of synthesizing IL-1b and GM-CSF and maybe one of the few defenses remaining under CD+ T cell-deficient conditions. The central hypothesis of this project is that cytokines such as IL-1b and GM-CSF are released by oral epithelial cells upon interaction with Candida and act as local stimulators of neutrophil anti-fungal functions. Using a human oral epithelial cell Candida albicans coculture model system the applicants will first determine whether this microorganism can trigger secretion of these potent neutrophil activating cytokines by oral epithelial cells. Once this goal is accomplished, mechanisms eliciting Candida-mediated cytokine responses will be explored. Finally, they will perform functional assays for these epithelial cell-derived cytokines as they relate to neutrophil activation of Candida phagocytosis and killing, using isolated neutrophils from healthy, HIV+ and Cyclosporine A-treated individuals. Given the fact that most fungal infections take place in an immunocompromised host, neutrophil priming by non-immune cell derived cytokines may be of paramount importance, not just in the initiation of a protective inflammatory response, but also in the prevention of fungal invasion into the deeper connective tissues of the oral mucosa. The studies proposed herein will be crucial in identifying oral epithelial cell-derived cytokines with the potential to prime neutrophil antifungal function in vitro. Identification of such cytokines may have future therapeutic applications in the treatment of oral candidiasis in the severely immunocompromised host.
描述:(逐字摘要)口咽念珠菌病 流行于因疾病或免疫抑制而免疫受损的患者 治疗。有趣的是,即使在免疫受损的患者中,侵入性口腔 念珠菌病很少见,似乎与其他危险因素有关。 比如严重的中性粒细胞减少症。提高抗药性的一种策略 机会性病原体是定义宿主细胞在 入侵过程,并增强与防御相关的反应 机制。令人信服的实验证据表明,主要效应器 负责清除念珠菌的细胞是中性粒细胞。中性粒细胞 在口腔感染部位迅速蓄积并参与 在局部控制假丝酵母菌的生长和入侵方面,人们知之甚少 关于负责调节这些事件的宿主信号。几个 细胞因子为中性粒细胞激活抗真菌功能提供信号, 包括白细胞介素1β(IL-1b)和粒-巨噬细胞集落 刺激因子(GM-CSF)。在T辅助细胞耗尽或 灭活,如HIV病或环孢素A治疗,中性粒细胞最多 可能通过刺激细胞因子来增强它们的抗真菌功能 来源于非免疫细胞。上皮细胞能够合成 IL-1b和GM-CSF,可能是CD+T下为数不多的防御措施之一 缺乏细胞的情况。这个项目的中心假设是 口腔上皮细胞分泌IL-1b和GM-CSF等细胞因子 与念珠菌相互作用并作为中性粒细胞抗真菌的局部刺激物 功能。人口腔上皮细胞白念珠菌共培养模型的建立 申请者将首先确定这种微生物是否可以 口服触发这些有效的中性粒细胞激活细胞因子的分泌 上皮细胞。一旦这一目标实现,机制就会引发 将探索念珠菌介导的细胞因子反应。最后,他们会 对这些上皮细胞衍生的细胞因子进行功能分析,因为它们 与中性粒细胞激活对念珠菌的吞噬和杀伤有关,应用 从健康、HIV+和环孢菌素A治疗的个体中分离出中性粒细胞。 鉴于大多数真菌感染发生在免疫功能低下的 非免疫细胞来源的细胞因子对宿主、中性粒细胞的启动可能是 最重要的是,不仅仅是在启动保护性炎症 应对措施,更是在防止真菌侵入的更深层次 口腔粘膜的结缔组织。在此建议的研究将是 在鉴定口腔上皮细胞来源的细胞因子方面具有关键作用 体外启动中性粒细胞抗真菌功能的可能性。身份识别 这类细胞因子可能在未来的治疗中有应用。 免疫功能严重受损的宿主中的口腔念珠菌病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anna I Dongari-Bagtzoglou其他文献

Anna I Dongari-Bagtzoglou的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anna I Dongari-Bagtzoglou', 18)}}的其他基金

Control of heterogeneous microbial communities using model-based multi-objective optimization
使用基于模型的多目标优化控制异质微生物群落
  • 批准号:
    10268262
  • 财政年份:
    2018
  • 资助金额:
    $ 21.74万
  • 项目类别:
Control of heterogeneous microbial communities using model-based multi-objective optimization
使用基于模型的多目标优化控制异质微生物群落
  • 批准号:
    10267334
  • 财政年份:
    2018
  • 资助金额:
    $ 21.74万
  • 项目类别:
Model of chemotherapy-induced mucositis
化疗引起的粘膜炎模型
  • 批准号:
    8871565
  • 财政年份:
    2014
  • 资助金额:
    $ 21.74万
  • 项目类别:
Model of chemotherapy-induced mucositis
化疗引起的粘膜炎模型
  • 批准号:
    8770223
  • 财政年份:
    2014
  • 资助金额:
    $ 21.74万
  • 项目类别:
Oral Epithelial Cells, Candida and PMN Activation
口腔上皮细胞、念珠菌和 PMN 激活
  • 批准号:
    7932529
  • 财政年份:
    2009
  • 资助金额:
    $ 21.74万
  • 项目类别:
ORAL INFECTION AND INFLAMMATION IN TRANSPLANT PATIENTS
移植患者的口腔感染和炎症
  • 批准号:
    7719123
  • 财政年份:
    2008
  • 资助金额:
    $ 21.74万
  • 项目类别:
ORAL CANDIDA
口腔念珠菌
  • 批准号:
    7719112
  • 财政年份:
    2008
  • 资助金额:
    $ 21.74万
  • 项目类别:
ORAL INFECTION AND INFLAMMATION IN TRANSPLANT PATIENTS
移植患者的口腔感染和炎症
  • 批准号:
    7607625
  • 财政年份:
    2007
  • 资助金额:
    $ 21.74万
  • 项目类别:
ORAL CANDIDA
口腔念珠菌
  • 批准号:
    7607610
  • 财政年份:
    2007
  • 资助金额:
    $ 21.74万
  • 项目类别:
ORAL INFECTION AND INFLAMMATION IN TRANSPLANT PATIENTS
移植患者的口腔感染和炎症
  • 批准号:
    7377365
  • 财政年份:
    2006
  • 资助金额:
    $ 21.74万
  • 项目类别:

相似海外基金

Candida and Candidiasis Conference 2023
2023 年念珠菌和念珠菌病会议
  • 批准号:
    10682982
  • 财政年份:
    2023
  • 资助金额:
    $ 21.74万
  • 项目类别:
Functional analysis of the signaling adaptor protein during oral candidiasis
口腔念珠菌病期间信号转接蛋白的功能分析
  • 批准号:
    23H03076
  • 财政年份:
    2023
  • 资助金额:
    $ 21.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Discovery of bacterial consortia to treat recurrent vulvovaginal candidiasis: a generalizable platform for phenotypic microbial community screening
发现治疗复发性外阴阴道念珠菌病的细菌群落:表型微生物群落筛查的通用平台
  • 批准号:
    10383360
  • 财政年份:
    2022
  • 资助金额:
    $ 21.74万
  • 项目类别:
Development of theranostics system for oral candidiasis
口腔念珠菌病治疗诊断系统的开发
  • 批准号:
    22K10128
  • 财政年份:
    2022
  • 资助金额:
    $ 21.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Host and Fungal Regulation of Type 17 Immunity to Oral Candidiasis
17 型口腔念珠菌病免疫的宿主和真菌调节
  • 批准号:
    10551422
  • 财政年份:
    2022
  • 资助金额:
    $ 21.74万
  • 项目类别:
The development of invasive candidiasis prevention based on interactions between gastrointestinal microbiota and Candida species
基于胃肠道微生物群和念珠菌物种之间相互作用的侵袭性念珠菌病预防的发展
  • 批准号:
    20K17477
  • 财政年份:
    2022
  • 资助金额:
    $ 21.74万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Host and Fungal Regulation of Type 17 Immunity to Oral Candidiasis
17 型口腔念珠菌病免疫的宿主和真菌调控
  • 批准号:
    10673918
  • 财政年份:
    2022
  • 资助金额:
    $ 21.74万
  • 项目类别:
Mechanisms of renal protection against disseminated candidiasis
抵抗播散性念珠菌病的肾脏保护机制
  • 批准号:
    10376250
  • 财政年份:
    2021
  • 资助金额:
    $ 21.74万
  • 项目类别:
Role of environmental iron in Candida albicans cell wall remodeling and its effect on host-pathogen interaction during oropharyngeal candidiasis
环境铁在口咽念珠菌病期间白色念珠菌细胞壁重塑中的作用及其对宿主-病原体相互作用的影响
  • 批准号:
    10647656
  • 财政年份:
    2021
  • 资助金额:
    $ 21.74万
  • 项目类别:
(Mis)Managing Microbiomes: Experiences and Challenges with Chronic Vulvovaginal Candidiasis in Primary Health Care
(错误)管理微生物组:初级卫生保健中慢性外阴阴道念珠菌病的经验和挑战
  • 批准号:
    457221
  • 财政年份:
    2021
  • 资助金额:
    $ 21.74万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了